Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCK

Exclusion Criteria

• •3. enrollment does not exceed the subject count specified
• •4. the subject agrees to a second Informed Consent document and data collection specific to the second TKA.
• •1. Skeletally immature (less than 21 years of age) at time of implantation.
• •2. Has an overt infection at the time of implantation.
• •3. Has inadequate neuromuscular status (e.g., prior paralysis, fusion, and/or inadequate abductor strength), poor bone stock, poor skin coverage around the joint which would make the procedure unjustifiable.
• •4. Currently enrolled in another clinical investigation which would affect the endpoints of this protocol.
• •5. Has documented substance abuse issues.
• •6. Has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study.
• •7. Currently incarcerated or has impending incarceration.
• •8. Has a medical condition, as judged by the Investigator, that would interfere with the subject's ability to comply with the requirements of the protocol.